DICE Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
DICE Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2023.
  • DICE Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 47.3M shares, a 26.6% increase year-over-year.
  • DICE Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39.4M shares, a 218% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 47.3M +9.95M +26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 47.2M +9.93M +26.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 39.4M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-15
Q3 2022 37.5M +29.9M +396% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 37.4M +35.1M +1562% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 37.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 7.55M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 2.25M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.